Our rescue experiments further demonstrated that the promotion of cancer progression induced by miR-29b inhibitor was neutralized by siRNA-ETV4, suggesting that inhibition of ETV4 conferred the suppressive role of miR-29b in CRC progression. This evidence concerns the gene ETV4 and colorectal carcinoma.